Ep 47: Non-Metastatic Muscle-Invasive Bladder Cancer AUA (2024 Update)

Incontinence after Prostate Treatment: AUA/GURS/SUFU Guideline (2024 Amendent)

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder (2024)

Diagnosis, Management, and Follow-Up of the Incidentally Discovered Adrenal Mass: CUA Guideline Endorsed by the AUA

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline (2024)

We discuss Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline (2024 update).

In this episode we discuss the 2024 Amendment of Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

In this episode we discuss the 2023 amendment to "Advanced Prostate Cancer: AUA/SUO Guideline" https://www.auanet.org/guidelines-and-quality/guidelines/advanced-prostate-cancer

In this episode we discuss "Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline (2023)" https://www.auanet.org/guidelines-and-quality/guidelines/non-metastatic-upper-tract-urothelial-carcinoma

In this episode we discuss the 2023 update to "Early Detection of Prostate Cancer: AUA/SUO Guideline". https://www.auanet.org/guidelines-and-quality/guidelines/early-detection-of-prostate-cancer-guidelines

In this episode we discuss the 2023 amendment to the AUA guidelines for urethral stricture disease. https://www.auanet.org/guidelines-and-quality/guidelines/urethral-stricture-guideline